Baptist one of the first to join trial of drug to prevent COVID complications
The trial of Quellor, a drug to tame inflammatory response in COVID-19, is for people already sick and with underlying conditions.
The trial of Quellor, a drug to tame inflammatory response in COVID-19, is for people already sick and with underlying conditions.
If the study can be replicated, it’s possible drugs already in use could be quickly repurposed to fight cytokine storm.
Tennessee’s diversity, size and urban-to-rural ratio are thought to be assets for drug-maker hoping to iron out vaccine distribution wrinkles.
The bio-services firm commits to creating 561 more jobs that pay $63,749 on average, and to making a $212.9 million capital investment.
Tennessee Attorney General’s Office is joining the Federal Trade Commission in challenging the proposed change in hospital ownership.
From 450 contact tracing interviews last week, the Health Department sees transmission is happening when people take masks off in restaurants, in gyms and in small social gatherings.
Drug gives a super supply of antibodies, more than the body can make on its own. “I think it’s well worth the small amount of risk it takes,” says Andy Shepherd.
Cognate BioServices, which has been contract-manufacturing in Memphis since 2007, seeks 15 years of property tax breaks that would save the company $52 million in return for the jobs and investment. However, the firm would still pay $65.4 million in taxes during the same period.
Federal agency says proposed acquisition would substantially reduce competition and health care costs would rise, according to its complaint.
St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center will offer a testing site for the Phase 3 clinical trial and are seeking 500 participants.
If the field hospital has to open, the region will be in a mess, Dr. Richard Walker says, and health care workers will be scarce.
FedEx is in daily contact with stakeholders in the COVID-19 vaccine supply chain, from manufacturers and distributors to government agencies to some sites where vaccines will be administered.
Wright Medical has about 700 employees in the Memphis area.
By the third week in November, Pfizer expects it will have the final data required to apply to the FDA for emergency-use authorization.
The previously in-person conference has been replaced by a two-hour webinar, another casualty of the coronavirus.
Some evidence suggests workers are infecting others when they let their guard down outside patient rooms.
The event is part of a statewide emphasis on the flu vaccine; free COVID-19 tests will also be available.
Medical device maker Stryker Corp. last week reported strong third quarter earnings and momentum in the extremities and trauma business heading into 2021 after the planned addition of Wright Medical.
Clinic that serves the Hispanic community in Shelby County has 15 years’ experience knowing how to send the right message. It’s giving the Health Department a boost to reach people who need to hear the COVID-19 messages.
Memphis doctors who violated False Claims Act in filing higher charges agree to pay for overbilling Medicare.
Certification shows processes in place to standardize high-quality care.
New Regional One clinic offers specialists for a variety of post-COVID symptoms, including those that last for weeks.
Because the merger would leave Memphis with only two hospital systems, antitrust issues have required Federal Trade Commission review.
People behind the COVID pressure-valve facilities in Shelby County are ready to go to work if the surge overwhelms hospital capacity.
Not only has MLM Memphis – formerly CirQuest Labs – added employees and space since being purchased last summer, its founder anticipates the lab may triple in size within five years.